The MEP Pathway: A New Target for the Development of Herbicides, Antibiotics and Antimalarial Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|19|2391-2400

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.19, 2004-07, pp. : 2391-2400

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Methylerythritol Phosphate (MEP) Pathway for Isoprenoid Biosynthesis as a Target for the Development of New Drugs Against Tuberculosis

By  

Current Medicinal Chemistry, Vol. 18, Iss. 9, 2011-03 ,pp. : 1325-1338

Bentham Science Publishers

Access to resources Recommend Favorite

6-Oxopurine Phosphoribosyltransferase: A Target for the Development of Antimalarial Drugs

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 16, 2011-08 ,pp. : 2085-2102

Bentham Science Publishers

Access to resources Recommend Favorite

Geminin as A Molecular Target for the Development of New Anticancer Drugs

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-04 ,pp. : 461-462

Bentham Science Publishers

Access to resources Recommend Favorite

Neurogenesis as a New Target for the Development of Antidepressant Drugs

By  

Current Pharmaceutical Design, Vol. 20, Iss. 23, 2014-05 ,pp. : 3763-3775

Bentham Science Publishers

Access to resources Recommend Favorite

New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics

By  

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-01 ,pp. : 4357-4378

Bentham Science Publishers

Access to resources Recommend Favorite